MedPath
TGA Approval

MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridge (423350)

423350

MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridge

Stada Pharmaceuticals Australia Pty Ltd

August 29, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/665f8e7c3dcccdaf357bfc34fc5ad1e0.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/9cf9dabf4aa43a5cc93862caa9d5a0b3.pdf

Active Ingredients

apomorphine hydrochloride hemihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridge (423350) - TGA 批准文号 | MedPath